Cerberus Announces Its Support of the Merger of Grifols and Talecris

NEW YORK, June 7, 2010 - Cerberus Capital Management, L.P. commented today on the announcement
that Grifols S.A. has entered into an agreement to acquire its portfolio
company Talecris Biotherapeutics Holding Corp. for a combination of cash and
newly issued Grifols non-voting shares. Cerberus controls an affiliate that
owns approximately 49% of the outstanding common stock of Talecris.

"We are excited about the prospect of becoming shareholders of Grifols.
Led by Victor Grifols, Grifols has long been known as a leading innovator in
the plasma-derived protein therapeutics field," commented W. Brett Ingersoll,
Co-Head of Private Equity at Cerberus. "Victor Grifols and his management
team have over thirty years of working together and proven experience in
building and managing a best-in-class company. We are confident that the
Grifols team, coupled with the proven team at Talecris, will continue to
build value for the combined company and its shareholders, including
Cerberus."

Steven F. Mayer, also Co-Head of Private Equity at Cerberus, stated, "We
had been very satisfied with the prospects of Talecris as a standalone entity
but the business logic behind the merger with Grifols is too compelling to
ignore. The companies have complementary geographic footprints, with
Talecris' strength in North America augmenting Grifols' strength
internationally, and each have premium products but in distinct therapeutic
categories. The combined companies will benefit from significant synergies,
permitting the companies to increase volumes of key therapies and capture
operating efficiencies, which will benefit the patient community."

The Cerberus affiliate, which will become a significant shareholder of
Grifols, has agreed, subject to certain conditions, to vote its Talecris
shares in favor of the merger.

About Cerberus Capital Management, L.P.

Established in 1992, Cerberus Capital Management, L.P., along with its
affiliates, is one of the world's leading private investment firms with
approximately US$23 billion under management. Through its team of investment
and operations professionals, Cerberus specializes in providing both
financial resources and operational expertise to help transform undervalued
companies into industry leaders for long-term success and value creation.
Cerberus is headquartered in New York City with affiliate and/or advisory
offices in the United States, Europe, the Middle East and Asia.

    Contact:
    For Cerberus Capital Management, L.P.

    Peter Duda, John Dillard
    Weber Shandwick
    +1-212-445-8213; +1-212-445-8052
    Cerberus Media Line: +1-212-891-1558
    media@cerberuscapital.com

Peter Duda, +1-212-445-8213, John Dillard, +1-212-445-8052, Cerberus Media Line: +1-212-891-1558, media at cerberuscapital.com, both of Weber Shandwick, for Cerberus Capital Management, L.P.